NCT06638931 2025-05-28ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Active not recruiting28 enrolled
NCT04099277 2021-08-31A Study of LY3435151 in Participants With Solid TumorsEli Lilly and CompanyPhase 1 Terminated2 enrolled 8 charts
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT00413075 2015-07-08Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaValerio TherapeuticsPhase 1 Completed121 enrolled
NCT00413322 2015-07-08Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsValerio TherapeuticsPhase 1 Completed35 enrolled
NCT00526149 2013-10-07BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Completed76 enrolled